Pharmaceutical News

RSS

Potential drug offers hope for therapy-resistant breast cancer patients

UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.

8 Aug 2017

Psychedelic drugs could help mental health patients recover from their symptoms

The altered state of consciousness and temporary lack of ego that results from using psychedelic drugs could help some mental health patients recover from their symptoms, according to academics at the University of Adelaide.

8 Aug 2017

Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain

The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether medical marijuana reduces opioid use among adults with chronic pain, including those with HIV.

8 Aug 2017

Discovery of new biological pathway involved in pain processing offers hope for new treatments

The discovery of a new biological pathway involved in pain processing offers hope of using existing cancer drugs to replace the use of opioids in chronic pain treatment, according to scientists at McGill University.

8 Aug 2017

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

The U.S. Food and Drug Administration has awarded orphan drug status to a promising immunotherapy vaccine developed at Roswell Park Cancer Institute.

8 Aug 2017

Researchers find clues to how chemotherapy drug fuels cancer spread from the breast to lungs

The very same treatment that thwarts breast cancer has a dark side – it can fuel the spread of the disease to the lungs.

8 Aug 2017

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

7 Aug 2017

Study: New Medicine Service could save NHS England £517.6m

A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.

From The University of Manchester 7 Aug 2017

New way of screening compounds may help speed up drug development

Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs for many diseases.

7 Aug 2017

Tiny medical device containing gold specks could boost effects of cancer drugs

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

7 Aug 2017

Proton pump inhibitor use not linked to increased risk of Alzheimer's disease

The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland.

7 Aug 2017

Study develops correction methods to provide more accurate estimates of opioid, heroin deaths

Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings.

7 Aug 2017

Compound derived from cannabis may alter blood levels of antiepileptic drugs

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used antiepileptic drugs.

7 Aug 2017

Opioid prescription use found to be more common among cancer survivors

A new study found that opioid prescription use is more common in cancer survivors than in individuals without a history of cancer.

7 Aug 2017

New method for evaluating drug safety can detect stress on cells at earlier stages

A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death.

4 Aug 2017

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.

4 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

A drug approved for private physicians to treat opioid addiction is being underprescribed, and a survey of addiction specialists suggests that many of them are not willing to increase their use of it, despite an expanding opioid addiction epidemic in the United States, according to research presented at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

Pharmaceutical News

Potential drug offers hope for therapy-resistant breast cancer patients

Psychedelic drugs could help mental health patients recover from their symptoms

Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain

Discovery of new biological pathway involved in pain processing offers hope for new treatments

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

Researchers find clues to how chemotherapy drug fuels cancer spread from the breast to lungs

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Study: New Medicine Service could save NHS England £517.6m

New way of screening compounds may help speed up drug development

Tiny medical device containing gold specks could boost effects of cancer drugs

Proton pump inhibitor use not linked to increased risk of Alzheimer's disease

Study develops correction methods to provide more accurate estimates of opioid, heroin deaths

Compound derived from cannabis may alter blood levels of antiepileptic drugs

Opioid prescription use found to be more common among cancer survivors

New method for evaluating drug safety can detect stress on cells at earlier stages

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Researchers explore why physicians underprescribe drug approved to treat opioid addiction

FDA approves new treatment for all HCV genotypes 1-6

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News